NASDAQ · Biotechnology
Minerva Neurosciences Inc (NERV)
$2.00
-5.66%
36
In band
Moving averages
SMA 200$4.84-58.68%
Company profile
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$127.58M
P/E ratioNone
EPS$-33.83
Beta0.014
Dividend yield0.00%
52-week high$8.80
52-week low$1.96
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
SAVA
Cassava Sciences Inc
IMUX
Immunic Inc
RSI 45
IVVD
Invivyd Inc
RSI 30
CHRS
Coherus Biosciences Inc
RSI 24
ARTV
Artiva Biotherapeutics Inc
RSI 23
TRDA
Entrada Therapeutics Inc
RSI 49
RSI alerts for NERV
An email when NERV closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 7:30 AM EST